AI-assisted Segmentation Tool for Brain Tumor MR Image Analysis
Journal of Imaging Informatics in Medicine · 08.07.2024 · 38 (1) · 74-83
DOI: 10.1007/s10278-024-01187-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Imaging Informatics in Medicine, online erschienen am 08.07.2024. Verfasst von Myungeun Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Medical Sciences, Chonnam National University, Gwangju, Republic of Korea. Hauptthemen laut MEDLINE: Brain Neoplasms, Magnetic Resonance Imaging, Glioblastoma, Artificial Intelligence. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government, This work was supported by a grant (BCRI23088) of Chonnam National University Hospital Biomedical Research Institute.
Abstract (Originalsprache)
TumorPrism3D software was developed to segment brain tumors with a straightforward and user-friendly graphical interface applied to two- and three-dimensional brain magnetic resonance (MR) images. The MR images of 185 patients (103 males, 82 females) with glioblastoma multiforme were downloaded from The Cancer Imaging Archive (TCIA) to test the tumor segmentation performance of this software. Regions of interest (ROIs) corresponding to contrast-enhancing lesions, necrotic portions, and non-enhancing T2 high signal intensity components were segmented for each tumor. TumorPrism3D demonstrated high accuracy in segmenting all three tumor components in cases of glioblastoma multiforme. They achieved a better Dice similarity coefficient (DSC) ranging from 0.83 to 0.91 than 3DSlicer with a DSC ranging from 0.80 to 0.84 for the accuracy of segmented tumors. Comparative analysis with the widely used 3DSlicer software revealed TumorPrism3D to be approximately 37.4% faster in the segmentation process from initial contour drawing to final segmentation mask determination. The semi-automated nature of TumorPrism3D facilitates reproducible tumor segmentation at a rapid pace, offering the potential for quantitative analysis of tumor characteristics and artificial intelligence-assisted segmentation in brain MR imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Institute of Medical Sciences, Chonnam National University, Gwangju, Republic of Korea.
- Department of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju, Republic of Korea.
- Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea.
- Department of Applied Bioengineering, Graduate School of Convergence Science and Technology, Seoul National University, Suwon, Republic of Korea.
- Department of Radiation Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
- Department of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju, Republic of Korea. amethyst_lee@naver.com.
Förderung
- This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government
- This work was supported by a grant (BCRI23088) of Chonnam National University Hospital Biomedical Research Institute
Zitieren
APA
Lee, M., Kim, J. H., Choi, W., & Lee, K. H. (2024). AI-assisted Segmentation Tool for Brain Tumor MR Image Analysis. Journal of Imaging Informatics in Medicine, 38(1), 74-83. https://doi.org/10.1007/s10278-024-01187-7
Vancouver
Lee M, Kim JH, Choi W, Lee KH. AI-assisted Segmentation Tool for Brain Tumor MR Image Analysis. Journal of Imaging Informatics in Medicine. 2024;38(1):74-83. doi:10.1007/s10278-024-01187-7
BibTeX
@article{Lee2024,
author = {Lee, Myungeun and Kim, Jong Hyo and Choi, Wookjin and Lee, Ki Hong},
title = {AI-assisted Segmentation Tool for Brain Tumor MR Image Analysis},
journal = {Journal of Imaging Informatics in Medicine},
year = {2024},
volume = {38},
number = {1},
pages = {74--83},
doi = {10.1007/s10278-024-01187-7}
}
EUVIMED